CLASS II ONGOING Device recall · Reported 9 Sep 2026 · FDA Enforcement Report

Citrasate, Liquid Acid Concentrate recalled

Fresenius Medical Care Renal Therapies Group is recalling Citrasate, Liquid Acid Concentrate for Bicarbonate Hemodialysis: Product Numbers, distributed nationwide in the US. The recall was initiated on 14 Jul 2026 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codes1) 08-2251-CA, UDI/DI 00840861101344, Lot Numbers: 26BXAC038; 2) 08-3251-CA, UDI/DI 00840861101351, Lot Numbers: 26BXAC039; 3) 13-2251-CA, UDI/DI 00840861101375, Lot Numbers: 26BXAC040, 26BXAC041.
Quantity recalled56,036 cs; 1,788 drums; 204 ea

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-3093-2026
FDA event ID
99543
Classification
Class II
Status
Ongoing
Recall initiated
14 Jul 2026
FDA classified
3 Sep 2026
Reported
9 Sep 2026
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

14 Jul 2026Recall initiated by company
3 Sep 2026Classified by FDA+51 days
9 Sep 2026Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Complaints of blue-green discoloration in product

Product as listed by the FDA

Citrasate, Liquid Acid Concentrate for Bicarbonate Hemodialysis: Product Numbers: 08-2251-CA, 08-3251-CA, 13-2251-CA; Liquid Acid Concentrate for Bicarbonate Hemodialysis

Where it was distributed

Worldwide distribution - US Nationwide and the country of Mexico.

Nationwide

Questions about this recall

Why was it recalled?

Complaints of blue-green discoloration in product

Which lots are affected?

1) 08-2251-CA, UDI/DI 00840861101344, Lot Numbers: 26BXAC038; 2) 08-3251-CA, UDI/DI 00840861101351, Lot Numbers: 26BXAC039; 3) 13-2251-CA, UDI/DI 00840861101375, Lot Numbers: 26BXAC040, 26BXAC041.

Where was it sold?

Worldwide distribution - US Nationwide and the country of Mexico.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

2 other products · FDA event 99543

This product is part of a recall event; the main page for the event is Granuflo Dry Acid Concentrate: Product Numbers: 0FD2251-3B recalled.

More recalls from Fresenius Medical Care Renal Therapies Group

All 34

Other Other Medical Devices recalls

All 13,778